This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Centaur, Inc.. Active years: 2015-2017.
Company Filing History:
Years Active: 2015-2017
Title: Annika Linde: Innovator in Antibiotic Therapies
Introduction
Annika Linde is a prominent inventor based in Manhattan, Kansas, known for her significant contributions to the field of antimicrobial therapies. With a total of four patents to her name, her groundbreaking work focuses on developing innovative solutions to combat microbial infections using unique peptide compounds derived from water buffalo.
Latest Patents
Among her most recent patents, Annika has developed two noteworthy innovations:
1. **Water buffalo derived dimeric peptide containing proline for antibiotic therapies** - This patent relates to novel antimicrobial agents and methods, emphasizing the potential for broad-spectrum antimicrobial activity. It provides essential nucleic acids and amino acid sequences that encode these antimicrobial agents, highlighting their applications in reducing microbe survival in both therapeutic and research contexts. Additionally, the patent covers compositions and articles of manufacture that incorporate these potent agents.
2. **Water buffalo derived peptide antibiotic therapies** - Similar to her first patent, this disclosure focuses on antimicrobial agents and their methods of use, showcasing broad-spectrum activity against various microbes. It includes crucial components for application in microbial treatment protocols and research, also encompassing compositions that utilize these effective antimicrobial agents.
Career Highlights
Annika's career at Centaur, Inc. is marked by her dedication to innovation in the field of antibiotic therapies. Her expertise in the development of antimicrobial agents has greatly advanced the understanding and treatment of microbial infections, providing new avenues for research and application.
Collaborations
Throughout her career, Annika has collaborated with talented individuals such as Luis Tonatiuh Melgarejo Garcia and Gerald Henry Lushington. These partnerships have been pivotal in enhancing the innovative capabilities of her work, fostering a collaborative environment that drives scientific discovery.
Conclusion
Annika Linde's innovative spirit and commitment to advancing antibiotic therapies stand as a significant contribution to the medical field. Her work not only addresses critical health challenges but also sets a precedent for future research in antimicrobial agents. As her patents continue to influence the industry, her legacy as an inventor is further solidified.